Detailed Information on Publication Record
2023
Efficacy of the intranasal application of azaperone for sedation in weaned piglets
SVOBODA, Martin, Jana BLAHOVA, Jiří JARKOVSKÝ, Adam ZACHARDA, Suzana HAJKOVA et. al.Basic information
Original name
Efficacy of the intranasal application of azaperone for sedation in weaned piglets
Authors
SVOBODA, Martin (203 Czech Republic, guarantor), Jana BLAHOVA (203 Czech Republic), Jiří JARKOVSKÝ (203 Czech Republic, belonging to the institution), Adam ZACHARDA (203 Czech Republic), Suzana HAJKOVA (203 Czech Republic), Jonas VANHARA (203 Czech Republic) and Jan VASEK (203 Czech Republic)
Edition
Veterinarni Medicina, Praha, Czech Academy of Agricultural Sciences, 2023, 0375-8427
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
40301 Veterinary science
Country of publisher
Czech Republic
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 0.700 in 2022
RIV identification code
RIV/00216224:14110/23:00131023
Organization unit
Faculty of Medicine
UT WoS
000981543900001
Keywords in English
behaviour; neuroleptic; pharmacodynamics; swine
Tags
International impact, Reviewed
Změněno: 21/6/2023 09:12, Mgr. Tereza Miškechová
Abstract
V originále
The aim of the study was to compare the efficacy of the intranasal and parenteral administration of azaperone in order to achieve pig sedation. A total of 32 weaned piglets divided into 4 groups (8 piglets in each group) were used. Group A was injected intramuscularly (i.m.) with azaperone (Stresnil (R), 40 mg/ml inj.; Elanco Animal Health) at a dose of 2 mg/kg of body weight (b.w.). Group B received a dose of 2 mg/kg b.w. of azaperone intranasally. Group C was given azaperone intranasally at a dose of 4 mg/kg b.w. Group D was given 1 ml of saline intranasally and served as the control group. The response to the defined stimulus (a blunt blow of a metal rod into a metal edge of a pen), the degree of salivation, movement level, body temperature and serum azaperone concentration were included in the trial. We found that in order to induce an adequate level of sedation comparable to the standard method of application, i.e., 2 mg/kg b.w. i.m., the intranasal administration of azaperone at a dose of 4 mg/kg body weight is required.